Evaluations

2016 Full Country Evaluations report - Uganda.

2016 Full Country Evaluations report - Cross country.

2016 Full Country Evaluations report - Mozambique.

Findings from the 2016 Gavi Full Country Evaluations for Zambia.

Findings from the 2016 Gavi Full Country Evaluations for Uganda.

Findings from the 2016 Gavi Full Country Evaluations for Mozambique.

Cross country findings from the 2016 Gavi Full Country Evaluations.

Findings from the 2016 Gavi Full Country Evaluations for Bangladesh.

2016 Full Country Evaluations report - Zambia.

2016 Full Country Evaluations report - Bangladesh.

Third annual Final Full Country Evaluations report (2015) - Gavi response

Findings from the 2015 Gavi Full Country Evaluations for Zambia.

Findings from the 2015 Gavi Full Country Evaluations for Bangladesh.

Findings from the 2015 Gavi Full Country Evaluations for Mozambique.

Findings from the 2015 Gavi Full Country Evaluations for Uganda.

Final Evaluation of Gavi Support to Albania FINAL REPORT November 13, 2015 Akaki Zoidze Ketevan Goguadze Ivdity Chikovani Draft Report: Final Evaluation of GAVI Support to Albania ii Table of Content Acknowledgements .......................................................................................................

Findings from the 2015 Gavi Full Country Evaluations CROSS-COUNTRY24, rue Salomon de Rothschild -92288 Suresnes -FRANCETl. : +33 (0)1 57 32 87 00 /Fax : +33 (0)1 57 32 87 87Web : www.carrenoir.comGAVIGAI_14_6999_LogoBlancQuad_GB30/07/2014QUIVALENCE QUADRICHROMIECYAN 40 % JAUNE 100 %CYAN 100 % MAGENTA 50 %CYAN 80 %Ce ch

1 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in

1 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in

1 2 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved i

Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in st

0 1 Acknowledgments The Gavi FCE team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in stakeholder consult

GHS-GAVI Evaluation 2015 Page 0 GAVI HSS/ISS/CSO SUPPORT EVALUATION FINAL REPORT October, 2015 GHS-GAVI Evaluation 2015 Page 1 ACKNOWLEDGEMENTS The Evaluation Team (Tettey & Associates) gratefully acknowledges the support and role of various institutions, and individuals to the success of the assignment. We wish to exp

Health System Strengthening Programme Evaluation Ethiopia Gavi provided funding for Ethiopia’s health system strengthening (HSS) programme from 2006-2012. The 2014 HSS support evaluation was commissioned by Gavi and conducted by JaRco Consulting PLC. BACKGROUND Recognising that achieving immunisation coverage is depend

Health System Strengthening Programme Evaluation Eritrea Gavi provided funding for Eritrea’s health system strengthening (HSS) programme from 2010-2014. The 2015 HSS support evaluation was commissioned by the Government of Eritrea and conducted by ECOSOC. BACKGROUND Recognising that achieving immunisation coverage is d

Final Evaluation of the GAVI Alliance Health System Strengthening Project (2007-2013) in the Republic of Yemen Final Report Sharon Beatty Musaid Almagribi April 14, 2014 1 Table of Contents Acknowledgements 2 List of Acronyms 3 Executive Summary 4 CHAPTER 1: BACKGROUND 6 I. Project description 6 II. Evaluation methodol

1 2 Contents ..................................................................................................................................................................... 1 Acknowledgments ...........................................................................................................................

PERFORMANCE ASSESSMENT OF GAVI-HSS INTERVENTIONS IN 20 TOWNSHIPS 2nd April 2014 Ministry of Health, World Health Organization, Country Office for Myanmar, International Health Policy Program, Thailand. Performance assessment of GAVI‐HSS interventions in 20 townships. Yangon, 2014. World Health Organization 2014 All ri

Health System Strengthening Programme Evaluation Afghanistan Gavi provided funding for Afghanistan's health system strengthening (HSS) programme from 2008-2013. The 2013 HSS support evaluation was commissioned by the government of Afghanistan and conducted by Governance Institute-Afghanistan. Recognising that achieving

Health System Strengthening Mid-term Programme Evaluation Myanmar Gavi provided funding for Myanmar’s health system strengthening (HSS) programme from 2012-2015. The 2013 mid-term evaluation of the HSS support programme was commissioned by the government of Myanmar and conducted by the Ministry of Health and the World

EVALUATION REPORT BURKINA FASO MAY 2014 EVALUATION OF GAVI SUPPORT TO HEALTH SYSTEM STRENGTHENING IN BURKINA FASO Abel Bicaba Ludovic Queuille Slim Haddad Drissa Sia 2 SUMMARY MANDATEAND METHODS The mandate concerns the evaluation of GAVI support for health system strengthening in Burkina Faso focusing on the different

E v a l u a t i o n o f t h e G A V I A l l i a n c e F u n d e d H e a l t h S y s t e m S t r e n g t h e n i n g P r o g r a m 1 P a g e G o v e r n a n c e I n s t i t u t e -A f g h a n i s t a n ( G I -A ) COUNTRY EVALUATION REPORT EVALUATION OF THE GAVI ALLIANCE FUNDED HEALTH SYSTEM STRENGTHENING PROGRAM AFGHAN

EVALUATION OF THE GAVI, THE VACCINE ALLIANCE SUPPORT TO HEALTH SYSTEM STRENGTHENING IN SOMALIA Evaluation conducted by: SCHOOL OF HUMANITIES AND SOCIAL SCIENCES UNIVERSITY OF ZAMBIA LUSAKA ZAMBIA FEBRUARY 2016 Contact details: Room 133 HSS Building PO BOX 32379 Great east road Lusaka Zambia Tel. +260211290475 Email: ec

Assessment of GAVI Support to Health System Strengthening in Tajikistan RFP No: AGSHST16062014 Final Report 16 September 2014Table of Contents Table of Contents .................................................................................................................................... 2 Acronyms ...............

GAVI, THE VACCINE ALLIANCE META-REVIEW OF COUNTRY EVALUATIONS OF GAVI’S HEALTH SYSTEM STRENGTHENING SUPPORT 18 MARCH 2016 FINAL REPORT Submitted by: Cambridge Economic Policy Associates Ltd CONTENTS Acronyms and abbreviations ..............................................................................................

Health System Strengthening Programme Evaluation Cameroon Gavi provided funding for Cameroon’s health system strengthening (HSS) programme from 2007-2012 but the grant was extended and reprogramming of the HSS grant was done but no formal evaluation had been conducted. The 2015 HSS support evaluation was commissioned b

Evaluation of the Gavi Health Systems Strengthening Support to Madagascar Evaluation Report 26 August 2015 John Snow, Inc. 1616 Fort Myer Drive, 16th Floor Arlington, VA 22209 USA Tel +1 703 528 7474 2 Table of Contents LIST OF TABLES AND FIGURES................................................................... 3 AC

Health System Strengthening Programme Evaluation Nepal Gavi provided funding for Nepal’s health system strengthening (HSS) programme through a pooled funding mechanism from 2010-2014. The 2015 HSS support evaluation was commissioned by Gavi and conducted by CEPA and HERD. BACKGROUND Recognising that achieving immunisat

Acknowledgment ....................................................................................................................................... 5 List of acronyms...................................................................................................................................... 7 Summary ......

Health System Strengthening Programme Evaluation Republic of Yemen Gavi provided funding for Yemen’s health system strengthening (HSS) programme from 2007-2013. The 2014 HSS support evaluation was commissioned by the government of Yemen and conducted by Sharon Beatty and Musaid Almagribi. BACKGROUND Recognising that ac

GAVI ALLIANCE EVALUATION OF GAVI HEALTH SYSTEMS STRENGTHENING SUPPORT TO NEPAL THROUGH THE POOLED FUNDING MECHANISM 31ST MARCH 2015 FINAL REPORT Submitted by: Cambridge Economic Policy Associates Ltd In association with: Health Research and Social Development Forum CONTENTS Acronyms and abbreviations ..................

Health System Strengthening Programme Evaluation Somalia Gavi provided funding for Cameroon’s health system strengthening (HSS) programme from 2011-2015 but the grant was extended and reprogramming of the HSS grant was done but no formal evaluation had been conducted. The 2015 HSS support evaluation was commissioned by

Health System Strengthening Programme Evaluation Burkina Faso Gavi provided funding for Burkina Faso’s health system strengthening (HSS) programme from 2008-2012. The 2014 HSS support evaluation was commissioned by Gavi and conducted by SERSAP, USI, and CHUM. BACKGROUND Recognising that achieving immunisation coverage

Global Alliance for Vaccines and Immunisation, Health System Support, Ethiopia, 2006-2012 Final Evaluation GAVI Alliance JaRco Consulting PLC Addis Ababa, Ethiopia 30thSeptember 2014 2 3 List of Tables ....................................................................................................... 5 List of Figu

Evaluation of Gavi Health Systems Support 2008-2013 in Sudan Abebe Alebachew and Shahd Osman 20 October 2015 iv Contents Acronyms and Abbreviations ...................................................................................................... vi Map of Sudan .....................................................

1 Government of the State of Eritrea Ministry of Health GAVI HSS -END OF GRANT EVALUATION ECOSOC September 2015 i Acknowledgement The evaluation team would like to express its appreciation and sincere thanks to the Director General of the Policy, Planning and HRD -Dr. Andom Ugbamariam and his staff. Special thanks also

Health System Strengthening Programme Evaluation Madagascar Gavi provided funding for Madagascar’s health system strengthening (HSS) programme from 2008-2013. The 2014 HSS support evaluation was commissioned by Gavi and conducted by John Snow, Inc. BACKGROUND Recognising that achieving immunisation coverage is dependen

Health System Strengthening Programme Evaluation Sudan Gavi provided funding for Sudan’s health system strengthening (HSS) programme from 2008-2013. The 2015 HSS support evaluation was commissioned by the Government of Sudan and conducted by Abebe Alebachew and Shahd Osman. BACKGROUND Recognising that achieving immunis

Health System Strengthening Programme Evaluation Ghana Gavi provided funding for Ghana’s health system strengthening (HSS) programme from 2007-2013. The 2015 HSS support evaluation was commissioned by the government of Ghana and conducted by Tettey & Associates. BACKGROUND Recognising that achieving immunisation covera

Health System Strengthening Programme Evaluation Tajikistan Gavi provided funding for Tajikistan’s health system strengthening (HSS) programme from 2008-2014. The 2014 HSS support evaluation was commissioned by Gavi and conducted by Curatio International Foundation. BACKGROUND Recognising that achieving immunisation co

Health System Strengthening Programme Evaluation Chad Gavi provided funding for Chad’s health system strengthening (HSS) programme from 2008-2012 but was extended beyond this period and no formal evaluation was conducted. The End of grant evaluation was requested by Gavi and the Ministry of Health (MSP) in Chad. Recogn

Second annual Full Country Evaluations report (2014) – Gavi response

The report assesses the extent to which the Advance Market Commitment (AMC) Pilot for Pneumococcal Vaccines has achieved its stated objectives and the overarching goal of reducing morbidity and mortality from pneumococcal disease. The evaluation also captures lessons learned.

Gavi Secretariat management response to the outcomes and impact evaluation of the Pilot Advance Market Commitment for Pneumococcal Vaccines.

A summary of the Advance Market Commitment Pilot for Pneumococcal Vaccines: Outcomes and impact evaluation.

This brief presents findings for Zambia from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

This report presents findings from the 2014 Gavi Full Country Evaluations (FCE).

This brief presents findings for Mozambique from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

This brief presents findings for Bangladesh from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

This brief presents lessons learned from human papillomavirus (HPV) vaccine demonstration in Mozambique and preparation for HPV national introduction in Uganda during the 2014 period of the Gavi Full Country Evaluations (FCE).

This brief presents findings for Uganda from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

The Vaccine Alliance’s responses to key recommendations are outlined in the accompanying Management Action Plan.

Gavi, the Vaccine Alliance Board Evaluation Advisory Committee (EAC) assessment of the quality and usefulness of the Norwegian Institute of Public Health’s "Evaluation of the Gavi Alliance Co-‐financing Policy".

This report presents the lessons learnt and recommendations from an evaluation of Gavi’s support to Bosnia and Herzegovina and its transition after funding ended. The evaluation was conducted by the Curatio International Foundation in 2014.

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response.

Process evaluation report of Pneumococcal Vaccine Introduction in Mozambique, Uganda and Zambia.

This report is the first annual progress report for the Full Country Evaluations project. It summarises work done in 2013 and evaluation activities to be taken forward in 2014.

The GAVI Secretariat’s management response to the evaluation of GAVI-Government of China Hepatitis B vaccination programme (2012, Abt Associates).

Evaluation of GAVI-Government of GAVI-Government of China Hepatitis B vaccination programme (2013, Abt Associates).

EVALUATION OF GAVI GENDER POLICY KEY RECOMMENDATIONS 14 December 2012 Submitted to: GAVI Alliance 2, Chemin des Mines 1211, Geneva 2 Switzerland Submitted by: ICF Macro, Inc. 11785 Beltsville Drive, Suite 300 Calverton, MD 20705 USA1 INTRODUCTION The GAVI Alliance public-private partnership brings together key stakehol

MANAGEMENT ACTION PLAN – EVALUATION OF THE GAVI ALLIANCE GENDER POLICY Date: 28 February 2013 1 Theme Recommendation Management Action Timeline/Responsibility Rationale, Design and Planning 1 Revision to gender policy: update rationale, strategic directions and commitments GAVI should commence a Gender Policy revision

EVALUATION OF GAVI GENDER POLICY FINAL REPORT 14 December 2012 Submitted to: GAVI Alliance 2, Chemin des Mines 1211, Geneva 2 Switzerland Submitted by: ICF Macro, Inc. 11785 Beltsville Drive, Suite 300 Calverton, MD 20705 USAi TABLE OF CONTENTS Table of Contents i Acronyms and Abbreviations iii Executive Summary iv Key

The Advance Market Commitment for Pneumococcal Vaccines Process and Design Evaluation Appendix February 15, 2013 Contents Appendix ............................................................................................................................................ 2 Appendix I. Timelines and inputs to design pro

Page 1 of 2 GAVI Secretariat Management Response to the Process and Design Evaluation of the Pilot Advance Market Commitment for Pneumococcal Vaccines Advance Market Commitments (AMCs) for vaccines aim to encourage the development and production of affordable vaccines tailored to the needs of developing countries. Foll

1 The Advance Market Commitment for Pneumococcal Vaccines Process and Design Evaluation Full Report February 15, 2013 Contents Preface ..................................................................................................................................................... 3 Acronyms and Abbreviations ......

1 EVALUATION OF GAVI SUPPORT TO CSOs Management Response – September 2012 Theme Recommendation Management Response Timeline/Responsibility Structure of GAVI CSO Support Focus of the support 1. GAVI CSO support should be restructured as a ‘single funding stream’ rather than two separate types of support. The focus shoul

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2011 COUNTRY EVALUATION REPORT -AFGHANISTAN Prepared by: Drs. Kayhan Natiq & Essa Tawfiq with support from: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .................................................

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CSOS 17 January 2012 EVALUATION REPORT (ANNEXES) Prepared by: CEPA LLP CONTENTS Annex 1: Glossary.................................................................................................................. 1 Annex 2: Bibliography and data sources .....................

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CSOS 17 January 2012 EVALUATION REPORT Prepared by: CEPA LLP CONTENTS Acronyms and abbreviations ................................................................................................ i Executive summary ............................................................

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CSOS 3 February 2012 RECOMMENDATIONS PAPER Prepared by: CEPA LLP CONTENTS Acronyms and abbreviations ................................................................................................ i 1. Introduction ..........................................................

ŀ GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -DRC Prepared by: Eliot Putnam, CEPA Associate and Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .........................................................................

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -INDONESIA Prepared by: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .............................................................................................. iii Exe

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -PAKISTAN Prepared by: Anita Zaidi with specific inputs from Ayesha Khan and support from: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations ...................................

GAVI ALLIANCE EVALUATION OF GAVI SUPPORT TO CIVIL SOCIETY ORGANISATIONS 17 January 2012 COUNTRY EVALUATION REPORT -ETHIOPIA Prepared by: Cambridge Economic Policy Associates LLP ii CONTENTS Acronyms and abbreviations .............................................................................................. iii Exec

This report presents the findings and lessons learnt from a review of the Accelerated Vaccine Introduction (AVI) Project undertaken by Cambridge Economic Policy Associates (CEPA) for the GAVI Alliance. The review period spans from February to June 2012.

Annexes to report presenting the findings and lessons learnt from a review of the Accelerated Vaccine Introduction (AVI) Project. The review period spans from February to June 2012.

This evaluation was commissioned by the GAVI Secretariat, on behalf of the IFFIm Board, to assess the extent to which the IFFIm has been an effective financing mechanism to raise money for immunisation and health systems in GAVI eligible countries.

This paper provides a response to the IFFIm Evaluation by the IFFIm Board of Directors. 

The International Financing Facility for Immunisation (IFFIm) concept is proven. IFFIm has allowed donor countries to make binding long-term commitments and convert these future cash flows into immediately available funds through the financial markets at a cost very close to that achieved by the World Bank. 

The World Bank has reviewed an evaluation report of the International Finance Facility for Immunisation (IFFIm) prepared by HLSP and dated June 2011. The World Bank provides services to IFFIm under the Treasury Management Agreement and this report substantially reviews those activities in the context of IFFIm’s overall performance as a financing vehicle.

Donors feel that the report presents valuable information about the goal effectiveness, costs effectiveness, and impacts in terms of lives saved by IFFIm. The evaluation shows, while highlighting constraints (size), lost opportunities (frontloading too early) and potential challenges (sustainability), that IFFIm has so far achieved impacts beyond those specifically targeted for immunisation.

GAVI Secretariat response to IFFIm evaluation which assessed both IFFIm’s efficacy as a financing mechanism, as well as the extent to which IFFIm has contributed to enhancing GAVI’s impact on immunisation and health.

The IFFIm evaluation assesses the extent to which IFFIm is an effective and efficient instrument to attract long-term, predictable donor funds and to frontload money to finance GAVI Alliance support for immunisation and health systems.

1 . A. 21 February 2011 Evaluation of the International Finance Facility for Immunisation (IFFIm) ANNEXES April 2011 HLSP, Sea Containers House, 20 Upper Ground, London SE1 9LZ, United Kingdom T +44 (0)20 7803 4545 F +44 (0)20 7803 4502, W www.hlsp.org Evaluation of the International Finance Facility for Immunisation (

This evaluation seeks to answer two high-level questions: to what extent has the GAVI Alliance met its four Strategic Goals (SGs); and to what extent has the GAVI Alliance added value at the global and country levels, over and above what would have been accomplished without the Alliance?

The goal of the AMC baseline study was to establish the environment prior to the AMC with baseline estimates for a selection of indicators related to the objectives of the AMC and to model counterfactual scenarios to ascertain the potential impact of the AMC vis-a-vis traditional financial and procurement strategies.

The Committee's overall assessment is that this is a credible and useful evaluation. The evaluation has yielded a number of important insights that will prove useful to the Board and Alliance as it prepares for and then implements its new strategy for the 2011-15 period.

The report provides contextual information on Mali’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country.

This annex aims to illustrate the type, nature and extent of GAVI funding to date for strategic goal 1 programmes.

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 3 in GAVI Phase II (2006-2010). GAVI's Strategic Goal 3 is: "to increase the predictability and sustainability of long-term financing for national immunisation programs."